
Releases
QuidelOrtho Slashes 2026 Outlook Amid China Market Turbulence
QuidelOrtho Corporation reported a 3% revenue increase for the second quarter of 2026, reaching $631 million, yet the company simultaneously downgraded its full-year financial guidance. The diagnostic firm cited significant demand headwinds in China, driven by evolving pricing policies that continue to stifle regional performance.

























